Related Experiment Video
Updated: Mar 7, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
Enterobacter Meningitis and Challenges in Treatment
Shaylika Chauhan1, Jawad Noor2, Balaji Yegneswaran3
1Resident Physician, Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School, Saint Peter's University Hospital , New Jersey, USA .
Abstract:
Neurosurgical interventions are rarely associated with meningitis with a very low incidence rate ranging from 1.1% to 2.5%. Gram negative bacillary meningitis first described in the 1940's, previously uncommon has been increasing in the recent past associated with advanced age, immunosuppression and neurosurgery. Enterobacter meningitis though relatively uncommon is recently increasing in incidence and treatment is frequently complicated due to resistance to antibiotics making this a challenging, difficult to treat infection that may be associated with adverse clinical outcomes. Here, we describe a case of a 27-year-old patient diagnosed with brain sarcoma at the age of four years, who presented with Enterobacter meningitis following a neurosurgical intervention for resection of a recurrent brain tumor (meningioma on pathology) and had a prolonged hospital stay with a difficult to treat infection.
Insights
This case study highlights a rare instance of Enterobacter meningitis following neurosurgery. This challenging infection, often resistant to antibiotics, underscores the need for vigilance in neurosurgical patients.
Area of Science:
- Infectious Diseases
- Neurosurgery
- Microbiology
Background:
- Neurosurgical interventions carry a low risk of meningitis (1.1%–2.5%).
- Gram-negative bacillary meningitis, once rare, is increasing, particularly in elderly, immunosuppressed, or post-neurosurgery patients.
- Enterobacter meningitis, though uncommon, is rising and poses treatment challenges due to antibiotic resistance.
More Related Videos
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urinary Tract Infection IV: Nursing Management
Urine Studies II: Urine Culture and Sensitivity Test
Development of Antibiotic Resistance
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

